Catalog Number 256089 |
Device Problem
Incorrect, Inadequate or Imprecise Result or Readings (1535)
|
Patient Problems
No Consequences Or Impact To Patient (2199); No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 01/17/2021 |
Event Type
malfunction
|
Manufacturer Narrative
|
A device evaluation and/or device history review is anticipated, but is not complete.Upon completion, a supplemental report will be filed.(b)(4).
|
|
Event Description
|
It was reported while testing for sars cov-2 7 false positive results were obtained.Repeat tests were performed using pcr and the results were negative.The customer stated they are testing asymptomatic patients.This test is not intended for use on asymptomatic patients and was therefore used off label.The customer stated results were not reported out so there was no report of patient impact.Eua#: (b)(4).
|
|
Manufacturer Narrative
|
H6: investigation summary: this statement is to summarize the investigation results regarding the complaint that alleges false positive results when using kit rapid detection of sars-cov-2 veritor ce (material # 256089), batch number 0311781.Bd quality performs a systematic approach to investigate false positive complaints.This approach involves review of manufacturing batch history records, testing of retention samples, and testing of customer returned samples, if applicable.An investigation and testing were performed on the batch number provided.The reported issue was unable to be confirmed.Photos were returned and reviewed.The problem could not be confirmed from the photographs provided.However, there is a trend against false positive results.Bd has initiated capa (corrective and preventive action) #1878253 to further investigate.Bd quality will continue to closely monitor for trends.
|
|
Event Description
|
It was reported while testing for sars cov-2 7 false positive results were obtained.Repeat tests were performed using pcr and the results were negative.The customer stated they are testing asymptomatic patients.This test is not intended for use on asymptomatic patients and was therefore used off label.The customer stated results were not reported out so there was no report of patient impact.Eua#: eua (b)(4).
|
|
Search Alerts/Recalls
|